Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate-Specific Antigen /Blood”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableLooking for participantsNCT06626386
What this trial is testing

Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)

Who this might be right for
Prostate Cancer
Heinrich-Heine University, Duesseldorf 200
Not applicableUnknownNCT03978299
What this trial is testing

Factors Associated With PSA False Negative and False Positive Results and the Impact on Patient's Health.

Who this might be right for
Prostate-Specific Antigen /Blood
Universidad Miguel Hernandez de Elche 2,527
Not applicableStudy completedNCT02825225
What this trial is testing

A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes

Who this might be right for
Prostate CancerLocal AnesthesiaProstate-Specific Antigen/Blood+8 more
University of Nove de Julho 750
Not applicableStudy completedNCT06029088
What this trial is testing

Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Ankara Etlik City Hospital 616
Not applicableUnknownNCT05448404
What this trial is testing

A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma

Who this might be right for
Multiple Myeloma
First Hospital of China Medical University 30